Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGK pseudogene 2 (AGKP2) is annotated as a pseudogene of acylglycerol kinase (AGK). Pseudogenes are non-functional segments of DNA that resemble functional genes but have lost their protein-coding ability or are otherwise inactive due to mutations. There is no evidence that AGKP2 is translated into a functional protein, nor is there reported involvement in biological processes, disease pathology, drug interactions, or clinical biomarker use[5][6]. AGKP2 should not be confused with the functional gene AGK (acylglycerol kinase), which has been described as an oncogene and potential therapeutic target, but AGKP2 itself is not a characterized therapeutic target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AGK pseudogene 2 (AGKP2).